IBEX Medical Systems
Latest round
- Series C
Last raised
- May 2025
Total raised
- $16M
Investors
- 10
About IBEX Medical Systems
Based in South Korea, IBEX Medical Systems specializes in the design and manufacture of advanced hyperbaric oxygen chambers for medical applications, enhancing treatment options for various health conditions. IBEX Medical Systems operates in the hyperbaric medical technology sector, providing innovative solutions since its founding in 2011.1 billion. The CEO, Brian Yoon, has a leadership history that supports the company’s strategic growth. IBEX Medical Systems specializes in the design and manufacture of hyperbaric oxygen chambers for medical and clinical applications. Their core products include the IBEX Tetragon and IBEX Omega, which are multi-place hyperbaric chambers that accommodate multiple patients simultaneously, as well as the IBEX Light and IBEX M2, designed for individual treatments. These chambers enhance oxygen supply to tissues, facilitating effective treatment for conditions such as carbon monoxide poisoning and non-healing wounds. The company also offers the MiraDry device for hyperhidrosis treatment, serving hospitals and healthcare providers globally, especially in the United States and Europe. IBEX Medical Systems generates revenue through direct sales of its hyperbaric oxygen chambers and related medical devices, targeting healthcare facilities. Transactions typically involve direct sales to hospitals and medical centers, which procure the chambers as capital investments. Pricing plans are structured around contracts that may include installation and after-sale support. The company also engages in partnerships for ongoing clinical research, reinforcing its relationships with clients and ensuring compliance with medical standards, which stabilizes its financial position in the medical device market. The company plans to expand its product offerings with new innovations aimed at improving patient outcomes, while also targeting new markets for growth beyond their current operations, focusing on regions such as North America and Europe by 2026.
Who invested in IBEX Medical Systems
10 investors across 3 rounds
See all investors in IBEX Medical Systems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IBEX Medical Systems
Who invested in IBEX Medical Systems?
IBEX Medical Systems has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IBEX Medical Systems raised?
IBEX Medical Systems has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did IBEX Medical Systems last raise money?
IBEX Medical Systems's most recent round on record is a Series C, in May 2025.
What does IBEX Medical Systems do?
Based in South Korea, IBEX Medical Systems specializes in the design and manufacture of advanced hyperbaric oxygen chambers for medical applications, enhancing treatment options for various health conditions.
Where is IBEX Medical Systems headquartered?
IBEX Medical Systems is headquartered in Wonju, South Korea.
Which VCs invest in companies like IBEX Medical Systems?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at IBEX Medical Systems's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like IBEX Medical Systems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.